Regencell Bioscience Holdings Stock Market Value
| RGC Stock | USD 5.91 0.04 0.68% |
| Symbol | Regencell |
Regencell Bioscience Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Regencell Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regencell Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regencell Bioscience.
| 12/07/2022 |
| 11/26/2024 |
If you would invest 0.00 in Regencell Bioscience on December 7, 2022 and sell it all today you would earn a total of 0.00 from holding Regencell Bioscience Holdings or generate 0.0% return on investment in Regencell Bioscience over 720 days. Regencell Bioscience is related to or competes with Phibro Animal, Sunshine Biopharma, Cosmos Health, Prestige Brand, Collegium Pharmaceutical, ANI Pharmaceuticals, and Procaps Group. Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine bioscience company More
Regencell Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regencell Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regencell Bioscience Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 43.32 | |||
| Value At Risk | (10.93) | |||
| Potential Upside | 22.58 |
Regencell Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regencell Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regencell Bioscience's standard deviation. In reality, there are many statistical measures that can use Regencell Bioscience historical prices to predict the future Regencell Bioscience's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (1.65) | |||
| Treynor Ratio | 0.1916 |
Regencell Bioscience Backtested Returns
Regencell Bioscience maintains Sharpe Ratio (i.e., Efficiency) of -0.0073, which implies the firm had a -0.0073% return per unit of risk over the last 3 months. Regencell Bioscience exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Regencell Bioscience's Variance of 87.66, insignificant risk adjusted performance, and Coefficient Of Variation of (5,677) to confirm the risk estimate we provide. The company holds a Beta of -0.91, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Regencell Bioscience are expected to decrease slowly. On the other hand, during market turmoil, Regencell Bioscience is expected to outperform it slightly. At this point, Regencell Bioscience has a negative expected return of -0.0695%. Please make sure to check Regencell Bioscience's total risk alpha, accumulation distribution, period momentum indicator, as well as the relationship between the potential upside and day median price , to decide if Regencell Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Regencell Bioscience Holdings has virtually no predictability. Overlapping area represents the amount of predictability between Regencell Bioscience time series from 7th of December 2022 to 2nd of December 2023 and 2nd of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regencell Bioscience price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Regencell Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 5.26 |
Regencell Bioscience lagged returns against current returns
Autocorrelation, which is Regencell Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Regencell Bioscience's stock expected returns. We can calculate the autocorrelation of Regencell Bioscience returns to help us make a trade decision. For example, suppose you find that Regencell Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Regencell Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Regencell Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Regencell Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Regencell Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Regencell Bioscience Lagged Returns
When evaluating Regencell Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Regencell Bioscience stock have on its future price. Regencell Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Regencell Bioscience autocorrelation shows the relationship between Regencell Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Regencell Bioscience Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock:Check out Regencell Bioscience Correlation, Regencell Bioscience Volatility and Regencell Bioscience Alpha and Beta module to complement your research on Regencell Bioscience. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Regencell Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.